847 reports of this reaction
1.6% of all RITONAVIR reports
#17 most reported adverse reaction
ABORTION SPONTANEOUS is the #17 most commonly reported adverse reaction for RITONAVIR, manufactured by AbbVie Inc.. There are 847 FDA adverse event reports linking RITONAVIR to ABORTION SPONTANEOUS. This represents approximately 1.6% of all 53,209 adverse event reports for this drug.
RITONAVIR has an overall safety score of 85 out of 100. Patients taking RITONAVIR who experience abortion spontaneous should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ABORTION SPONTANEOUS is a less commonly reported adverse event for RITONAVIR, but still significant enough to appear in the safety profile.
In addition to abortion spontaneous, the following adverse reactions have been reported for RITONAVIR:
The following drugs have also been linked to abortion spontaneous in FDA adverse event reports:
ABORTION SPONTANEOUS has been reported as an adverse event in 847 FDA reports for RITONAVIR. This does not prove causation, but indicates an association observed in post-market surveillance data.
ABORTION SPONTANEOUS accounts for approximately 1.6% of all adverse event reports for RITONAVIR, making it a notable side effect.
If you experience abortion spontaneous while taking RITONAVIR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.